Pain management practices bill some of the highest-value outpatient procedures in US healthcare. A single interventional session an RFA procedure, a spinal cord stimulator implant, a multi-level transforaminal injection can represent $1,500 to $30,000 in billable services.
So why are so many interventional pain practices collecting significantly less than they should?
The answer isn’t usually a single catastrophic billing failure. It’s a collection of quiet, systematic losses running simultaneously each one invisible in isolation, all of them adding up to a revenue gap that most pain management physicians never see clearly because nobody has ever measured it.
In our experience auditing pain management practices across the United States, we find the same revenue losses in nearly every practice. The dollar amounts vary. The categories almost never do.
Here is where the money goes and why it keeps going.
Reason #1 — Imaging Guidance Revenue Isn’t Being Captured
Fluoroscopic guidance (CPT 77003) and ultrasound guidance (CPT 76942) are separately billable for most interventional pain procedures. For a practice performing 15–20 imaging-guided procedures per day, these codes represent thousands of dollars in additional monthly revenue.
The problem isn’t that pain management physicians don’t know these codes exist. It’s that the billing for them is inconsistent — either the codes aren’t being billed at all on a portion of qualifying procedures, or they’re being billed without the required documentation that must accompany them.
To bill imaging guidance codes legitimately, three things must be present in the patient’s chart:
- Documentation that imaging guidance was used during the procedure
- A permanent image record retained in the chart
- A separate interpretation report documenting the provider’s review of the imaging
In most pain management practices we audit, imaging guidance is billed on 40–60% of qualifying procedures. The other 40–60% — the visits where the documentation wasn’t complete enough or the code simply wasn’t entered — represent uncaptured revenue on procedures that were already performed.
The annual impact: $25,000–$45,000 for a solo or two-physician pain practice.
Reason #2 — The Wrong Approach Code Is Being Used for Epidural Injections
This is one of the most expensive systematic coding errors in pain management — and one of the most invisible.
Epidural steroid injections are not a single CPT code. They have two distinct approaches — interlaminar and transforaminal — with entirely different code sets:
Interlaminar: CPT 62320–62323 (cervical/thoracic without and with imaging guidance; lumbar/sacral without and with imaging guidance)
Transforaminal: CPT 64479–64484 (cervical/thoracic single level and add-on; lumbar/sacral single level and add-on)
These codes have different reimbursement rates. They require different documentation. And they describe different procedures that are clearly distinguished in the procedure note.
In practices where billing defaults to one approach code regardless of what the procedure note documents — or where billing staff don’t know the distinction — the claim may be systematically undercoded (interlaminar billed when transforaminal was performed) or creating documentation mismatches that flag on audit.
The annual impact: $18,000–$35,000 from systematic approach code errors.
Reason #3 — RFA Prior Authorization Keeps Getting Denied at the First Submission
Radiofrequency ablation is one of the highest-reimbursement and most authorization-intensive procedures in pain management. When it’s done right, it generates $1,500–$3,000 per session. When the authorization is denied, the procedure is either delayed or the practice absorbs the cost.
The most common reason RFA authorizations are denied at first submission isn’t clinical — it’s documentation. Most commercial payers require evidence of two prior positive medial branch block responses before approving RFA. This means the authorization package must include:
- Both prior MBB procedure notes
- Documented percentage of pain relief in each note
- Documented duration of relief
- Payer-specific threshold applied (50% for some plans, 80% for others)
When authorization requests are submitted without this complete package — which is the default for most billing teams that haven’t been specifically trained on RFA authorization requirements — payers respond with a deficiency request. The practice has to locate the documentation, assemble it, and resubmit. The authorization is delayed by 3–4 weeks. The patient waits. The procedure revenue is pushed back.
For practices performing 8–12 RFA procedures per month, systematic first-submission authorization failures mean 3–4 delayed procedures every month — compounding into significant annual scheduling and revenue disruption.
The annual impact of RFA authorization management done correctly vs. incorrectly: $30,000–$55,000 in recovered and accelerated revenue.
Reason #4 — Multiple Procedure Reductions Are Being Applied Above the Contracted Rate
When a pain management specialist performs more than one procedure in a single session — routine in interventional pain practice — payers automatically reduce reimbursement on secondary procedures. Your payer contract specifies the applicable reduction percentage.
The problem: most pain management practices never verify that the reduction being applied matches the contracted rate.
This matters because payers don’t always apply the correct percentage. When a commercial payer contract specifies 50% multiple procedure reduction and the payer applies 60%, that extra 10% is being written off as a standard contractual adjustment on every qualifying claim — every session where multiple procedures were performed.
Nobody alerts the practice. No denial is generated. The payment arrives. It’s posted. The adjustment is applied. The balance zeros out.
The practice accepted an underpayment. It will accept the same underpayment next month. And the month after that.
In a practice billing two or more procedures per session on 60–70% of daily visits, an overapplied multiple procedure reduction of even 5–10% represents $18,000–$35,000 per year. Per underpaying payer. In practices with multiple commercial payers applying incorrect reductions, the annual total compounds significantly.
Reason #5 — SCS Permanent Implant Claims Are Getting Denied
Spinal cord stimulator procedures involve multiple distinct phases: trial electrode placement, trial assessment, permanent implant, and ongoing device management. Each phase has its own CPT codes and its own prior authorization requirements.
The most common and most expensive SCS billing failure: the trial authorization is obtained, the trial is successful, and the permanent implant is scheduled — without anyone having obtained a separate permanent implant authorization.
Trial authorization and permanent implant authorization are two different documents required by virtually every commercial payer. When a billing team assumes the trial authorization covers the permanent procedure, the practice performs a high-cost surgical procedure without confirmed coverage. The claim is denied. Retro-authorization may not be available. The practice absorbs the cost of a procedure that may represent $15,000–$30,000 in billed services.
This isn’t a rare edge case. It’s a consistent failure mode in practices where SCS authorization is managed as a single-phase process rather than two independent authorization tracks.
Reason #6 — E/M Visits Are Being Coded at 99213 for Every Patient
Pain management physicians manage patients with complex, overlapping chronic conditions. A follow-up visit for a patient with chronic low back pain, lumbar radiculopathy, failed back surgery syndrome, and comorbid depression — where the provider reviews recent imaging, adjusts a complex medication regimen, discusses the RFA candidacy, and documents functional outcome measures — is not a 99213.
Under 2021 AMA E/M guidelines, this visit supports 99214 or higher based on medical decision-making complexity or total time. Managing multiple chronic conditions simultaneously, reviewing diagnostic results, prescription drug management with monitoring requirements — these are the specific factors that support moderate complexity MDM and 99214.
Most pain management practices bill 99213 for the majority of established patient visits. The per-visit revenue difference under Medicare: approximately $40. Across 300 established patient visits per month with 60% qualifying for 99214: $7,200 per month. $86,400 per year.
From the exact same clinical work. Already being documented. Just being coded at the wrong level.
Reason #7 — Denied Claims Age Past the Appeal Window
Pain management denials are not simple to appeal. Medical necessity denials on interventional procedures require clinical documentation packages, functional outcome records, prior treatment documentation, and in many cases peer-to-peer review coordination. That work takes time — time that billing teams running on available capacity often don’t prioritize.
The result is familiar: denied claims sit in the AR aging queue. New claims take priority. The denial is noted but not worked. Days pass. Weeks pass.
Commercial payer appeal windows are 60–180 days from the denial date. Medicare allows 120 days. When those windows close, the denial is permanent. A $2,500 denied RFA claim that sat unworked for 90 days because the billing team didn’t have time to assemble the documentation for a formal appeal is now unrecoverable.
In a pain management practice with a denial rate above 12%, the annual revenue lost to expired appeal windows — claims that were recoverable but weren’t pursued — typically runs $30,000–$55,000.
What It Adds Up To
For a solo or two-physician interventional pain practice:
| Revenue Loss Category | Annual Estimated Impact |
|---|---|
| Imaging guidance not captured | $25,000 – $45,000 |
| ESI approach code errors | $18,000 – $35,000 |
| RFA authorization delays and failures | $30,000 – $55,000 |
| Multiple procedure reduction underpayments | $18,000 – $35,000 |
| SCS permanent implant denials | $15,000 – $30,000 |
| E/M undercoding | $50,000 – $90,000 |
| Expired appeal windows on denied claims | $30,000 – $55,000 |
| Total | $186,000 – $345,000 |
Every dollar in this table was earned. Every procedure was performed. Every patient was seen.
The money didn’t disappear clinically. It disappeared in the billing operation — through coding defaults that were never questioned, authorization workflows that weren’t built for interventional pain complexity, payment posting that accepted whatever arrived without comparing it to the contract, and a denial queue that nobody had time to work systematically.
What Stops the Losses
The revenue gaps described above don’t require new patients, new procedures, or new services to close. They require a billing operation that understands pain management specifically — and manages the revenue cycle the way interventional pain billing actually demands.
That means approach-code verification before every ESI claim. Imaging guidance documentation confirmation on every qualifying procedure. RFA authorization built around the MBB documentation package. SCS authorization tracked as two independent processes. Multiple procedure reductions reconciled against contracted rates at every payment posting. E/M levels coded at what the documentation supports. Denied claims worked by value — the $2,500 RFA denial before the $120 office visit denial.
Malakos Healthcare Solutions — Pain Management Billing
Malakos Healthcare Solutions provides specialized pain management billing and revenue cycle management for interventional pain practices across the United States. Based in Cheyenne, Wyoming, we serve practices nationwide through your existing EHR and practice management system — no migration, no long-term contracts.
Every engagement begins with a free billing audit that identifies your specific revenue losses in dollar terms — which categories, which payers, which amounts. No benchmarks. Your data.
Most pain management practices that complete a Malakos audit find the revenue gap is larger than they expected. All of them find it is actionable.
Schedule Your Free Pain Management Billing Audit
📞 +1 (307) 441-3431 ✉️ support@malakoshcs.com 🌐 malakoshealthcaresolutions.com
Related Reading
- Pain Management Billing Services in the USA
- Pain Management RCM — Complete Checklist for 2026
- Pain Management Case Study — $341K Revenue Recovery
- Payment Reconciliation Case Study — $94K Underpayment Recovery
- Denial Management Services
Malakos Healthcare Solutions | Pain Management Billing Services USA | Serving interventional pain practices nationwide since 2022
